Paper24985397
IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice.
Li D and 10 others. J Allergy Clin Immunol, 2014. Cited by 375 papers, by iCite.
Cite this record
ConductScience Library. IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice. Papers, record 24985397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24985397
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interleukins | Major topic |
| Lung | Major topic |
| Macrophages, Alveolar | Major topic |
| Receptors, Interleukin | Major topic |
| Animals | |
| Fibrosis | |
| Interleukin-1 Receptor-Like 1 Protein | |
| Interleukin-13 | |
| Interleukin-33 | |
| Lymphocytes | |
| Mice, Inbred C57BL | |
| Mice, Knockout | |
| Transforming Growth Factor beta1 |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 099251 | Wellcome Trust | United Kingdom | PubMed | |
| 18912 | Arthritis Research UK | United Kingdom | PubMed | |
| 19213 | Versus Arthritis | United Kingdom | PubMed | |
| G0901113 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20200518 | Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. | Nature | 2010 | https://conductscience.org/library/papers/20200518 | PubMed |
| 2 | 23172891 | Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice. | Gut | 2013 | https://conductscience.org/library/papers/23172891 | PubMed |
| 3 | 21113163 | The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. | Nat Immunol | 2011 | https://conductscience.org/library/papers/21113163 | PubMed |
| 4 | 11076310 | Lymphokines in bleomycin-induced lung injury in bleomycin-sensitive C57BL/6 and -resistant BALB/c mice. | Exp Lung Res | 2000 | https://conductscience.org/library/papers/11076310 | PubMed |
| 5 | 18667700 | IL-33 exacerbates antigen-induced arthritis by activating mast cells. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18667700 | PubMed |
| 6 | 20937871 | IL-33 is a crucial amplifier of innate rather than acquired immunity. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20937871 | PubMed |
| 7 | 8842674 | Bleomycin: revival of an old drug. | Gen Pharmacol | 1996 | https://conductscience.org/library/papers/8842674 | PubMed |
| 8 | 23837438 | Interleukin-33 potentiates bleomycin-induced lung injury. | Am J Respir Cell Mol Biol | 2013 | https://conductscience.org/library/papers/23837438 | PubMed |
| 9 | 22772564 | Mechanisms of fibrosis: therapeutic translation for fibrotic disease. | Nat Med | 2012 | https://conductscience.org/library/papers/22772564 | PubMed |
| 10 | 12819012 | Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. | Am J Pathol | 2003 | https://conductscience.org/library/papers/12819012 | PubMed |
| 11 | 23078031 | Anti-interleukin-33 inhibits cigarette smoke-induced lung inflammation in mice. | Immunology | 2013 | https://conductscience.org/library/papers/23078031 | PubMed |
| 12 | 22702477 | Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice. | Allergy | 2012 | https://conductscience.org/library/papers/22702477 | PubMed |
| 13 | 21246230 | Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. | Clin Rheumatol | 2011 | https://conductscience.org/library/papers/21246230 | PubMed |
| 14 | 20412815 | Over-expression of IL-33 leads to spontaneous pulmonary inflammation in mIL-33 transgenic mice. | Immunol Lett | 2010 | https://conductscience.org/library/papers/20412815 | PubMed |
| 15 | 23420878 | Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. | J Exp Med | 2013 | https://conductscience.org/library/papers/23420878 | PubMed |
| 16 | 19841166 | IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. | J Immunol | 2009 | https://conductscience.org/library/papers/19841166 | PubMed |
| 17 | 18802081 | IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. | J Immunol | 2008 | https://conductscience.org/library/papers/18802081 | PubMed |
| 18 | 22371395 | Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. | J Immunol | 2012 | https://conductscience.org/library/papers/22371395 | PubMed |
| 19 | 15032599 | Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. | Annu Rev Immunol | 2004 | https://conductscience.org/library/papers/15032599 | PubMed |
| 20 | 21832918 | Modeling pulmonary fibrosis with bleomycin. | Curr Opin Pulm Med | 2011 | https://conductscience.org/library/papers/21832918 | PubMed |
Cited by254
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 375 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42909980 | Spatiotemporal Immune-Fibroblast Crosstalk in Pulmonary Fibrosis: From Failed Repair to Fibrotic Niche Formation. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42909980 | PubMed |
| 42712896 | Pathogenic group 2 innate lymphoid cells as drivers of lung fibrosis in severe asthma. | Front Immunol | 2026 | https://conductscience.org/library/papers/42712896 | PubMed |
| 42629416 | Collaborative functionality between three types of inflammation in idiopathic pulmonary fibrosis. | Nat Immunol | 2026 | https://conductscience.org/library/papers/42629416 | PubMed |
| 42587773 | Molecular Systems Architecture of Fibrotic Lung Microenvironment in Idiopathic Pulmonary Fibrosis. | Cells | 2026 | https://conductscience.org/library/papers/42587773 | PubMed |
| 42528868 | The IL-33-ILC2 axis: a key regulator of type 2 immunity in respiratory disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42528868 | PubMed |
| 42521538 | Blocking interleukin 33 reduces joint, systemic, and lung inflammatory responses in the combined collagen-induced arthritis-inhalant endotoxin exposure model. | J Pharmacol Exp Ther | 2026 | https://conductscience.org/library/papers/42521538 | PubMed |
| 42374013 | COPD Biologics: Right Patient, Right Pathway, Right Time. | Pulm Ther | 2026 | https://conductscience.org/library/papers/42374013 | PubMed |
| 42352278 | Mechanisms of the IL-33/ST2 Signaling Axis in Regulating Bone Metabolism. | Biomolecules | 2026 | https://conductscience.org/library/papers/42352278 | PubMed |
| 42307017 | Spatial and Phenotypic Heterogeneity of ILC Subsets in Mouse Lung Under Type 2 Inflammatory Conditions. | Eur J Immunol | 2026 | https://conductscience.org/library/papers/42307017 | PubMed |
| 42015168 | Impact of particulate matter 2.5 on a mouse model of lung adenocarcinoma. | BMC Pulm Med | 2026 | https://conductscience.org/library/papers/42015168 | PubMed |
| 41997918 | Hdac11 promotes idiopathic pulmonary fibrosis through macrophage M2-type polarization and myofibroblast accumulation by inhibiting Parkin-dependent mitophagy. | Nat Commun | 2026 | https://conductscience.org/library/papers/41997918 | PubMed |
| 41951242 | Immunological mechanisms and therapeutic approaches in pulmonary fibrosis. | Eur Respir Rev | 2026 | https://conductscience.org/library/papers/41951242 | PubMed |
| 41939867 | Multi-omics integration and machine learning reveal gut-immune signatures in idiopathic pulmonary fibrosis: insights from bulk RNA-seq, single-cell profiles, spatial transcriptomics, and experimental validation. | Front Immunol | 2026 | https://conductscience.org/library/papers/41939867 | PubMed |
| 41733715 | Mechanistic insights into the evolution from spasmolytic polypeptide-expressing metaplasia to gastric cancer (Review). | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/41733715 | PubMed |
| 41712459 | GATA2 controls alveolar macrophage inflammatory gene expression and metabolic function. | JCI Insight | 2026 | https://conductscience.org/library/papers/41712459 | PubMed |
| 41624831 | Iron homeostasis and macrophage polarization in pulmonary fibrosis: mechanisms and therapeutic perspectives. | Front Immunol | 2025 | https://conductscience.org/library/papers/41624831 | PubMed |
| 41601146 | Neuroimmune circuits in respiratory pathophysiology: decoding molecular crosstalk for precision therapeutic targeting. | Ann Med | 2026 | https://conductscience.org/library/papers/41601146 | PubMed |
| 41565804 | The transition from monocyte to tissue-resident macrophage requires DHPS. | Nature | 2026 | https://conductscience.org/library/papers/41565804 | PubMed |
| 41465219 | Activation of TSLP-IL-9 Axis Hinders the Antifibrotic Effect of ST2 Deficiency in Pulmonary Fibrosis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465219 | PubMed |
| 41459489 | Unpacking the anti-fibrotic arsenal: molecular mechanisms and therapeutic translation of MSC-derived exosomes in pulmonary fibrosis. | Front Immunol | 2025 | https://conductscience.org/library/papers/41459489 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL13 | 3596 | PubTator's text mining | https://conductscience.org/library/genes/3596 | NCBI Gene |
| IL18 | 3606 | PubTator's text mining | https://conductscience.org/library/genes/3606 | NCBI Gene |
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| IL33 | 90865 | PubTator's text mining | https://conductscience.org/library/genes/90865 | NCBI Gene |
| ST2 | 6761 | PubTator's text mining | https://conductscience.org/library/genes/6761 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24985397
GET https://conductscience.org/api/papers/v1/24985397/references?page=2